| NCT ID | NCT04364334 |
| Status | Recruiting |
| Phase | — |
| Sponsor | UMC Utrecht |
| Condition | Knee Pathology |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000,000 participants |
| Start Date | 2017-01 |
| Primary Completion | 2100-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000,000 participants in total. It began in 2017-01 with a primary completion date of 2100-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Rationale: In view of patient care, patient characteristics and treatment parameters are registered for all patients visiting the Mobility Clinic of the University Medical Center Utrecht for orthopaedic knee treatment. Patients also fill out questionnaires for function, pain and mobility of the knee, before and after treatment. Objective: The main objective of this registry is to collect patient characteristics and treatment parameters together with data from the questionnaires in a database. This knee registry can be used for future research questions. Study design: This is a longitudinal observational registry. Study population: All patients that visit the Mobility Clinic will be asked to participate in the knee registry. Patients that meet one or more of the following criteria will be excluded: are below the age of 16, not able or willing to sign the broad consent form, not being able to read and understand Dutch language, or receiving medical treatment for their knee elsewhere. Main study parameters/endpoints: Data will be collected for future research for which the purpose is not known at this time. When new research will be conducted, study parameters will be set. A study application has to be submitted to the institutional ethical review board of the University Medical Center Utrecht. Patients do not need to be asked permission for the use of their data for each study individually. Only when additional information is needed. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The burden for patients to participate in this registry is minimal and consists of time. Any future results may be beneficial for patients. Participation or refusal to participate in the registry has no consequences for their treatment.
Eligibility Criteria
Inclusion Criteria: * Receives orthopaedic knee surgery or conservative knee treatment (advice, physiotherapy, injections etc) at the UMC Utrecht; * Able to read and understand Dutch language; * Is able and willing to signs the broad consent form. Exclusion Criteria: * Receives no treatment (refusal of surgery or treatment); * Receives treatment elsewhere.
Contact & Investigator
Roel Custers, Dr
PRINCIPAL INVESTIGATOR
Orthopedic surgeon
Frequently Asked Questions
Who can join the NCT04364334 clinical trial?
This trial is open to participants of all sexes, studying Knee Pathology. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04364334 currently recruiting?
Yes, NCT04364334 is actively recruiting participants. Contact the research team at l.kornegoor@umcutrecht.nl for enrollment information.
Where is the NCT04364334 trial being conducted?
This trial is being conducted at Utrecht, Netherlands.
Who is sponsoring the NCT04364334 clinical trial?
NCT04364334 is sponsored by UMC Utrecht. The principal investigator is Roel Custers, Dr at Orthopedic surgeon. The trial plans to enroll 1,000,000 participants.